Clinical Trials Browser

OTHER × glembatumumab vedotin × Clear all

NCT03473691 2024-12-09

Breast50

Phase EARLY_PHASE1 Withdrawn

Triple Negative Breast Neoplasms

NCT02713828 2019-07-16

PrE0504

Phase 1/2 Terminated

13 enrolled 12 charts

Squamous Cell Carcinoma of the Lung